Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Hydroxyurea treatment unexpectedly restored hair color from gray to dark brown in an older woman.

Some breast cancer chemotherapy can cause permanent hair loss.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

The scalp lotion helped increase hair thickness in cancer patients undergoing chemotherapy.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

The treatment is safe and shows promise for metastatic breast cancer.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Combining immune checkpoint inhibitors with other cancer therapies increases skin side effects in Asian patients.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

MK-5108 is safe and shows potential against tumors, especially alone.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Using tissue adhesive in hair transplants improves results and patient satisfaction, with fewer complications.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Most patients' skin darkening after sclerotherapy fades on its own within 6-24 months.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.